O	0	6	Breast
O	7	13	cancer
O	14	18	risk
O	19	28	reduction
O	28	29	-
O	29	30	-
O	30	32	is
O	33	35	it
O	36	44	feasible
O	45	47	to
O	48	56	initiate
O	57	58	a
O	59	69	randomised
O	70	80	controlled
O	81	86	trial
O	87	89	of
O	90	91	a
B-intervention	92	101	lifestyle
I-intervention	102	114	intervention
I-intervention	115	124	programme
O	125	126	(
O	126	133	ActWell
O	133	134	)
O	135	141	within
O	142	143	a
O	144	152	national
O	153	159	breast
O	160	169	screening
O	170	179	programme
O	179	180	?

O	181	187	Breast
O	188	194	cancer
O	195	197	is
O	198	201	the
O	202	206	most
O	207	215	commonly
O	216	225	diagnosed
O	226	232	cancer
O	233	236	and
O	237	240	the
O	241	247	second
O	248	253	cause
O	254	256	of
O	257	263	cancer
O	264	270	deaths
O	271	278	amongst
O	279	284	women
O	285	287	in
O	288	291	the
O	292	294	UK
O	294	295	.

O	296	299	The
O	300	309	incidence
O	310	312	of
O	313	316	the
O	317	324	disease
O	325	327	is
O	328	338	increasing
O	339	342	and
O	343	345	is
O	346	353	highest
O	354	356	in
O	357	362	women
O	363	367	from
O	368	373	least
O	374	382	deprived
O	383	388	areas
O	388	389	.

O	390	392	It
O	393	395	is
O	396	405	estimated
O	406	410	that
O	411	417	around
O	418	420	42
O	420	421	%
O	422	424	of
O	425	428	the
O	429	436	disease
O	437	439	in
O	440	444	post
O	444	445	-
O	445	455	menopausal
O	456	461	women
O	462	467	could
O	468	470	be
O	471	480	prevented
O	481	483	by
O	484	493	increased
O	494	502	physical
O	503	511	activity
O	512	515	and
O	516	526	reductions
O	527	529	in
O	530	537	alcohol
O	538	544	intake
O	545	548	and
O	549	553	body
O	554	561	fatness
O	561	562	.

O	563	569	Breast
O	570	576	cancer
O	577	584	control
O	585	595	endeavours
O	596	601	focus
O	602	604	on
O	605	613	national
O	614	623	screening
O	624	634	programmes
O	635	638	but
O	639	644	these
O	645	647	do
O	648	651	not
O	652	659	include
O	660	674	communications
O	675	677	or
O	678	691	interventions
O	692	695	for
O	696	700	risk
O	701	710	reduction
O	710	711	.

O	712	716	This
O	717	722	study
O	723	728	aimed
O	729	731	to
O	732	738	assess
O	739	742	the
O	743	754	feasibility
O	755	757	of
O	758	766	delivery
O	766	767	,
O	768	778	indicative
O	779	786	effects
O	787	790	and
O	791	804	acceptability
O	805	807	of
O	808	809	a
O	810	819	lifestyle
O	820	832	intervention
O	833	842	programme
O	843	852	initiated
O	853	859	within
O	860	863	the
O	864	867	NHS
O	868	876	Scottish
O	877	883	Breast
O	884	893	Screening
O	894	903	Programme
O	904	905	(
O	905	912	NHSSBSP
O	912	913	)
O	913	914	.

O	915	916	A
O	917	918	1
O	918	919	:
O	919	920	1
O	921	931	randomised
O	932	942	controlled
O	943	948	trial
O	949	950	(
O	950	953	RCT
O	953	954	)
O	955	957	of
O	958	961	the
O	962	963	3
O	964	969	month
O	970	977	ActWell
O	978	987	programme
O	988	989	(
O	989	998	focussing
O	999	1001	on
O	1002	1006	body
O	1007	1013	weight
O	1013	1014	,
O	1015	1023	physical
O	1024	1032	activity
O	1033	1036	and
O	1037	1044	alcohol
O	1044	1045	)
O	1046	1052	versus
B-control	1053	1058	usual
I-control	1059	1063	care
O	1064	1073	conducted
O	1074	1076	in
O	1077	1080	two
O	1081	1088	NHSSBSP
O	1089	1094	sites
O	1095	1102	between
O	1103	1107	June
O	1108	1112	2013
O	1113	1116	and
O	1117	1124	January
O	1125	1129	2014
O	1129	1130	.

O	1131	1142	Feasibility
O	1143	1154	assessments
O	1155	1163	included
O	1164	1175	recruitment
O	1175	1176	,
O	1177	1186	retention
O	1186	1187	,
O	1188	1191	and
O	1192	1200	fidelity
O	1201	1203	to
O	1204	1212	protocol
O	1212	1213	.

O	1214	1224	Indicative
O	1225	1233	outcomes
O	1234	1238	were
O	1239	1247	measured
O	1248	1250	at
O	1251	1259	baseline
O	1260	1263	and
O	1264	1265	3
O	1266	1271	month
O	1272	1278	follow
O	1278	1279	-
O	1279	1281	up
O	1282	1283	(
O	1283	1287	body
O	1288	1294	weight
O	1294	1295	,
O	1296	1301	waist
O	1302	1315	circumference
O	1315	1316	,
O	1317	1323	eating
O	1324	1327	and
O	1328	1335	alcohol
O	1336	1342	habits
O	1343	1346	and
O	1347	1355	physical
O	1356	1364	activity
O	1364	1365	)
O	1365	1366	.

O	1367	1369	At
O	1370	1375	study
O	1376	1379	end
O	1379	1380	,
O	1381	1382	a
O	1383	1396	questionnaire
O	1397	1405	assessed
O	1406	1417	participant
O	1418	1430	satisfaction
O	1431	1434	and
O	1435	1446	qualitative
O	1447	1457	interviews
O	1458	1466	elicited
O	1467	1472	women
O	1472	1473	'
O	1473	1474	s
O	1474	1475	,
O	1476	1483	coaches
O	1483	1484	,
O	1485	1488	and
O	1489	1502	radiographers
O	1502	1503	'
O	1504	1515	experiences
O	1515	1516	.

O	1517	1528	Statistical
O	1529	1537	analysis
O	1538	1542	used
O	1543	1546	Chi
O	1547	1554	squared
O	1555	1560	tests
O	1561	1564	for
O	1565	1576	comparisons
O	1577	1579	in
O	1580	1591	proportions
O	1592	1595	and
O	1596	1602	paired
O	1603	1604	t
O	1605	1610	tests
O	1611	1614	for
O	1615	1626	comparisons
O	1627	1629	of
O	1630	1635	means
O	1635	1636	.

O	1637	1643	Linear
O	1644	1654	regression
O	1655	1663	analyses
O	1664	1668	were
O	1669	1678	performed
O	1678	1679	,
O	1680	1688	adjusted
O	1689	1692	for
O	1693	1701	baseline
O	1702	1708	values
O	1708	1709	,
O	1710	1714	with
O	1715	1720	group
O	1721	1731	allocation
O	1732	1734	as
O	1735	1736	a
O	1737	1742	fixed
O	1743	1749	effect
O	1749	1750	.

O	1751	1752	A
O	1753	1756	pre
O	1756	1757	-
O	1757	1760	set
O	1761	1772	recruitment
O	1773	1779	target
O	1780	1782	of
B-total-participants	1783	1785	80
O	1786	1791	women
O	1792	1795	was
O	1796	1804	achieved
O	1805	1811	within
O	1812	1814	12
O	1815	1820	weeks
O	1821	1824	and
B-total-participants	1825	1827	65
O	1828	1829	(
O	1829	1831	81
O	1831	1832	%
O	1832	1833	)
O	1834	1846	participants
O	1847	1848	(
B-intervention-participants	1848	1850	29
O	1851	1863	intervention
O	1863	1864	,
B-control-participants	1865	1867	36
O	1868	1875	control
O	1875	1876	)
O	1877	1886	completed
O	1887	1888	3
O	1889	1894	month
O	1895	1906	assessments
O	1906	1907	.

O	1908	1912	Mean
O	1913	1916	age
O	1917	1920	was
B-age	1921	1923	58
I-age	1924	1925	±
I-age	1926	1927	5
I-age	1927	1928	.
I-age	1928	1929	6
I-age	1930	1935	years
O	1935	1936	,
O	1937	1941	mean
O	1942	1945	BMI
O	1946	1949	was
O	1950	1952	29
O	1952	1953	.
O	1953	1954	2
O	1955	1956	±
O	1957	1958	7
O	1958	1959	.
O	1959	1960	0
O	1961	1963	kg
O	1963	1964	/
O	1964	1965	m
O	1965	1966	(
O	1966	1967	2
O	1967	1968	)
O	1969	1972	and
O	1973	1977	many
O	1978	1979	(
O	1979	1981	44
O	1981	1982	%
O	1982	1983	)
O	1984	1992	reported
O	1993	1994	a
O	1995	2001	family
O	2002	2009	history
O	2010	2012	of
O	2013	2019	breast
O	2020	2026	cancer
O	2026	2027	.

O	2028	2031	The
O	2032	2039	primary
O	2040	2048	analysis
O	2049	2050	(
B-outcome	2050	2058	baseline
I-outcome	2059	2063	body
I-outcome	2064	2070	weight
I-outcome	2071	2079	adjusted
O	2079	2080	)
O	2081	2087	showed
O	2088	2089	a
O	2090	2101	significant
O	2102	2109	between
O	2110	2115	group
O	2116	2126	difference
O	2127	2136	favouring
O	2137	2140	the
O	2141	2153	intervention
O	2154	2159	group
O	2160	2162	of
O	2163	2164	2
O	2164	2165	.
O	2165	2167	04
O	2168	2170	kg
O	2171	2172	(
O	2172	2174	95
O	2174	2175	%
O	2176	2178	CI
O	2179	2180	-
O	2180	2181	3
O	2181	2182	.
O	2182	2184	24
O	2185	2187	kg
O	2188	2190	to
O	2191	2192	-
O	2192	2193	0
O	2193	2194	.
O	2194	2196	85
O	2197	2199	kg
O	2199	2200	)
O	2200	2201	.

O	2202	2213	Significant
O	2213	2214	,
O	2215	2225	favourable
O	2226	2233	between
O	2234	2239	group
O	2240	2251	differences
O	2252	2256	were
O	2257	2261	also
O	2262	2270	detected
O	2271	2274	for
B-outcome	2275	2278	BMI
O	2278	2279	,
B-outcome	2280	2285	waist
I-outcome	2286	2299	circumference
O	2299	2300	,
B-outcome	2301	2309	physical
I-outcome	2310	2318	activity
O	2319	2322	and
B-outcome	2323	2330	sitting
I-outcome	2331	2335	time
O	2335	2336	.

O	2337	2342	Women
B-outcome	2343	2348	rated
I-outcome	2349	2352	the
I-outcome	2353	2362	programme
I-outcome	2363	2369	highly
O	2370	2373	and
O	2374	2376	70
O	2376	2377	%
O	2378	2382	said
O	2383	2387	they
O	2388	2393	would
O	2394	2403	recommend
O	2404	2406	it
O	2407	2409	to
O	2410	2416	others
O	2416	2417	.

O	2418	2429	Recruitment
O	2429	2430	,
O	2431	2440	retention
O	2440	2441	,
O	2442	2452	indicative
O	2453	2460	results
O	2461	2464	and
O	2465	2476	participant
O	2477	2490	acceptability
O	2491	2498	support
O	2499	2502	the
O	2503	2514	development
O	2515	2517	of
O	2518	2519	a
O	2520	2530	definitive
O	2531	2534	RCT
O	2535	2537	to
O	2538	2545	measure
O	2546	2550	long
O	2551	2555	term
O	2556	2563	effects
O	2563	2564	.

O	2565	2568	The
O	2569	2574	trial
O	2575	2578	was
O	2579	2589	registered
O	2590	2594	with
O	2595	2602	Current
O	2603	2613	Controlled
O	2614	2620	Trials
O	2621	2622	(
O	2622	2636	ISRCTN56223933
O	2636	2637	)
O	2637	2638	.
